ATC Group: G02CX07 Elinzanetant

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of G02CX07 in the ATC hierarchy

Level Code Title
1 G Genito urinary system and sex hormones
2 G02 Other gynecologicals
3 G02C Other gynecologicals
4 G02CX Other gynecologicals
5 G02CX07

Active ingredients in G02CX07

Active Ingredient

Elinzanetant is a non-hormonal, selective neurokinin 1 (NK-1) and 3 (NK-3) receptors antagonist. It blocks NK-1 and NK-3 receptors signalling on kisspeptin/neurokinin B/dynorphin (KNDy) neurons, which is postulated to normalise neuronal activity involved in thermo- and sleep regulation.

Related product monographs

Document Type Information Source  
 LYNKUET Soft capsule MPI, EU: SmPC European Medicines Agency (EU)

United States medicines

Medicines classified under this ATC code globally

Austria (AT)

Estonia (EE)

Lithuania (LT)

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.